MedPath

RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users

Phase 4
Recruiting
Conditions
Contraception
Contraceptive Usage
Birth Control
Family Planning
Interventions
Other: Additional Standardized Counseling
Registration Number
NCT04558229
Lead Sponsor
Planned Parenthood of the St. Louis Region and Southwest Missouri
Brief Summary

Clinician counseling for implant users should involve an explanation of the likelihood of irregular bleeding and the possibility of continued or frequent bleeding throughout three years of use. If that counseling does not provide specifics of the actual distribution of bleeding patterns described in published literature, there remains the real possibility of biased or directed counseling, leading to an inaccurate and exaggerated expectation of potential bleeding changes. This study aims to evaluate if a standardized script accompanied by a visual aid regarding expected bleeding profiles, with intention to remove any possibility of negative or positive framing, could change users' expectations and satisfaction with their method, leading to lower discontinuation rates.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
348
Inclusion Criteria
  • Presenting at the health center to receive an etonogestrel-releasing subdermal implant (Nexplanon) for primarily contraceptive benefits
  • Ability to consent in English
Exclusion Criteria
  • Have used an etonogestrel-releasing subdermal implant (Nexplanon) within the 12 weeks prior to enrollment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Additional Standardized CounselingAdditional Standardized Counseling-
Primary Outcome Measures
NameTimeMethod
Nexplanon Discontinuation Rates6 months

Based subjects' self-reported ability to cope with various changes in bleeding patterns, and other demographic information, we will analyze whether an association exists between those who discontinue their method use early due to troublesome bleeding and the counseling they received on the day of method insertion.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Planned Parenthood of the St. Louis Region and Southwest Missouri

🇺🇸

Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath